A group that includes Amazon founder Jeff Bezos has invested $2.25 billion for a majority stake in Plymouth-based HistoSonics.

In a letter to the Republican chairman of the House Oversight Committee, Democrats call for greater transparency.

Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic ...

Hill previously wrapped production on the Apple feature Outcome, which is slated for release in spring of 2026 and stars Hill ...

In statements to the USA TODAY Network, both the University of Rochester Medical Center, or URMC, and Regeneron noted they don't receive federal funding connected to the mRNA research cuts announced ...

A convicted rapist who killed a Connecticut visiting nurse at a halfway house pleaded guilty to murder and was sentenced ...

Trump Mobile, a new enterprise from the Trump Organization, has pushed back its T1 Phone release date from August to October.

The acclaimed horror pic and the female-fueled 'Freaky Friday' sequel are expected to end up in a close race for No.1 at the ...

The company’s models give both health practitioners and patients a view of internal anatomy so they can accurately rehearse ...

Scientists have discovered how harmful clumps inside brain cells—linked to diseases like ALS and Huntington’s—form, and found a way to break them apart. These sticky tangles of RNA develop inside tiny ...

Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.

Detailed price information for Cognition Therapeutics Inc (CGTX-Q) from The Globe and Mail including charting and trades.